FDA Approves First Treatment for Group of Progressive Interstitial Lung Diseases - FDA Press Releases

The FDA approves treatment for patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait).

from FDA Press Releases RSS Feed https://ift.tt/38C7W1V
via IFTTT